Replies to post #19520 on BioCurex, Inc.(fka BOCX)

[Gold Seeker]

Opportunity, Moro has stated that a positive rapid test would be followed by the more accurate assay test. That dictates the need for a successful assay test first.

The question is why Moro is not talking. Why doesn't he want to answer your questions? Moro cannot tell us that communicating with shareholders will compromise his position in obtaining funding. If anything, positive communication always increases the demand for the stock. Is it the lack of anything positive to relate. Is it the need to hide something negative. It is one or the other.

[Kag]

Opportunity Knocking,
You might consider a possible fly in the ointment. If anyone ever attempts to sell a RECAF rapid test, the likely only possibility would be Inverness. Let's assume for this discussion (but a prudent investor would not make the assumption based on what is currently in the public domain) that inverness is making progress with a RECAF rapid test. Inverness has to know that BioCurex is in financial trouble with its Smithline loan which is secured with a lien on essentially all of BioCurex's assets. If Inverness wanted to cut BioCurex out of the picture, it seems that all the elements for doing that are in place. All Inverness would have to do is keep quiet and wait until a default on the Smithline loan occurs and then indicate to Smithline that they might be interested in the assets at a distressed price. Time is on Inverness' side, but not on BioCurex's. kag